<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="research-article"        dtd-version="1.4">
            <front>

                <journal-meta>
                                    <journal-id></journal-id>
            <journal-title-group>
                                                                                    <journal-title>Harran Üniversitesi Tıp Fakültesi Dergisi</journal-title>
            </journal-title-group>
                            <issn pub-type="ppub">1304-9623</issn>
                                        <issn pub-type="epub">1309-4025</issn>
                                                                                            <publisher>
                    <publisher-name>Harran University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id/>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Clinical Sciences</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Klinik Tıp Bilimleri</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <trans-title-group xml:lang="en">
                                    <trans-title>Investigation of DNA Damage in Rats in Chronically Exposed to Sub-Hypnotic Dose Desflurane</trans-title>
                                </trans-title-group>
                                                                                                                                                                                                <article-title>Sıçanlarda, Subhipnotik Doz Kronik Desfluran Maruziyetinde, DNA Hasarının Araştırılması</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                <name>
                                    <surname>Altay</surname>
                                    <given-names>Nuray</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Yıldırım</surname>
                                    <given-names>Zeynep Baysal</given-names>
                                </name>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20150415">
                    <day>04</day>
                    <month>15</month>
                    <year>2015</year>
                </pub-date>
                                        <volume>12</volume>
                                        <issue>1</issue>
                                        <fpage>44</fpage>
                                        <lpage>52</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20141001">
                        <day>10</day>
                        <month>01</month>
                        <year>2014</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20141105">
                        <day>11</day>
                        <month>05</month>
                        <year>2014</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 2004, Journal of Harran University Medical Faculty</copyright-statement>
                    <copyright-year>2004</copyright-year>
                    <copyright-holder>Journal of Harran University Medical Faculty</copyright-holder>
                </permissions>
            
                                                                                                <trans-abstract xml:lang="en">
                            <p>Background: In this study the aim was to research the DNA damage in rats whose chronic desfluran gasesexposed.Metods: This experimental study, after the Ethic Committe permission was made in Harran UniversityMedical Faculty Farmacology Department. For the study 200-230 gr 18 female albino wistar rats were used.After and before the study care and the feeding of the rats were made in the Harran University experimentalanimal laboratory. Rats divided in two groups (Group I: Desfluran, Grup II: Control ). For the anaesthesiapump system we used special planned plastic plate. Datex Ohmeda Tec 6 plus vaporizator was used to GroupI rats to whom hypnotic doses desflurane was given ( % 0,5-1 ). İn the second group same mechanism wasused but the desflurane vaporizator was closed. Each group %50 O2 and desflurane gas mixture was given inthe 5lt/minute speed. In the environment the desflurane and the O2 concentration were measured continouslyby the anaesthesia gases monitor ( criticare ). The condition of exposing to the gases, again 1 hour in 5 days.Outside of experiment, rats waited in room condition and in their cages. At the end of fifth day, 50mg/kg withpenthotal sodium, general anaesthesia was made and their extremities were fixed in the supine position fixingto the table. Blood samples were taken from intracardiac undertaking. The blood samples were takenheparinized tubes and put in cold condition in the special plate. Then sent to the Harran University MedicalFaculty Biochemical Department. The experimental rats sacrificed and then burried with lime. DNAdamagewas measured in taken bloods mononuclear leukocytes with Comet Assay method. İn addition, in same bloodsamples were measured antioxidant capacity and oxidative stress.Results: During the study, general anaesthesia conditions in any rat were not seen and rats were continuedtheir normal activity. DNAdamage, antioxidant capacity and oxidative stress were similar in both groups.Conclusions: It was concluded that not occur in a significant DNA damage, compared to the controlgroup in rats exposed chronically desflurane.</p></trans-abstract>
                                                                                                                                    <abstract><p>Amaç: Bu çalışmada, subhipnotik dozda, kronik desfluran gazına maruz kalan sıçanlardaki DNA hasarınınaraştırılması amaçlandı.Materyal ve metod: Deneysel çalışma, Harran Üniversitesi Tıp Fakültesi Etik Kurulu izni sonrasında aynıfakültenin Farmakoloji Laboratuarında yapıldı. Çalışma için 200-230gr ağırlığında 18 adet dişi Wistar türüalbino sıçan kullanıldı. Sıçanların çalışma öncesi ve sonrasındaki beslenme ve bakımları, HarranÜniversitesi Deney Hayvanları Laboratuarında yapıldı. Sıçanlar randomize 2 gruba ayrıldı (GrupI=Desfluran, Grup II= Kontrol). Anestezik gaz verme sistemi için, özel olarak tasarlanmış plastik kaplarkullanıldı. Grup I&#039; de sıçanlara, Datex-Ohmeda Tec6 Plus vaporizatörü ile hipnoz oluşturmayacak dozlarda(%0.5-1) desfluran verildi. Grup II&#039;de de aynı düzenek kullanıldı, ancak desfluran vaporizatörü kapalıtutuldu. Her iki grupta deney düzeneğine %50 oksijen-hava karışımı 5 litre /dakika taze gaz akışı hızındaverildi. Ortamdaki desfluran ve oksijen konsantrasyonları bir anestezik gaz monitörü (Criticare ®) ile sürekliolarak ölçüldü. Çalışma gazlarına maruz kalma durumu 5 gün boyunca günde 1 saat olacak şekildetekrarlandı. Deney dışındaki saatlerde sıçanlar kendi kafeslerinde oda şartlarında bakıldılar. Beşinci gününsonunda 50 mg/kg intraperitoneal pentothal ile anestezisi sağlanan sıçanlar, supin pozisyonundaekstremitelerden masaya tespit edildi. Sıçanlardan intrakardiak girişimle kan örnekleri alındı. Alınan kanlarheparinli tüplere aktarılarak özel bir kap içerisinde, soğuk ortamda, en kısa sürede Harran Üniversitesi TıpFakültesi Biyokimya Anabilim Dalı Laboratuarına ulaştırıldı. Deney hayvanları kan alındıktan sonrasakrifiye edilip, üzerlerine kireç kaymağı dökülüp toprağa gömüldüler. Alınan kanlardaki mononükleerlökositlerinden Comet Assey yöntemi ile DNAhasarları ölçüldü. Ayrıca aynı kan örneklerinden, antioksidankapasite ve oksidatif stress indeks değerleri analiz edildi.Bulgular: Deneysel çalışma sırasında hiçbir sıçanda genel anestezi durumu oluşmazken, tüm sıçanlar 5 günboyunca normal aktivitelerini sürdürdüler. Kan örneklerinden çalışılan DNAhasarı, antioksidan kapasite veoksidatif stres indeks değerleri, her iki grupta benzer bulundu.Sonuç: Kronik olarak desflurana maruz kalan sıçanlarda, kontrol grubuna göre, belirgin bir DNA hasarınınoluşmadığı sonucuna varıldı.</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>Desfluran</kwd>
                                                    <kwd>  kronik maruziyet</kwd>
                                                    <kwd>  DNAhasarı</kwd>
                                            </kwd-group>
                            
                                                <kwd-group xml:lang="en">
                                                    <kwd>Desflurane</kwd>
                                                    <kwd>  chronic exposure</kwd>
                                                    <kwd>  DNAdamage</kwd>
                                            </kwd-group>
                                                                                                                                        </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">1) Kayhan Z. Klinik Anestezi. Logos Yayıncılık Tic.
Aş. Ankara, 1997: 56.
2) Ronald D. Miller:Anesthesia, Churchill Livingstone,
Philadelphia, 2000: 166.
3) Hoerauf K.H, Schrögendorfer K.F, Wiesner G,
Gruber M, Spacek A, Kress H.G and Rüdiger H.W.
Sister chromatid exchange in human lymphocytes
exposed to isoflurane and nitrous oxide in vitro. British
Journal of Anesthesia 1999; 82(2):268-70.
4) Karabıyık L, Şardaş S, Polat U, Kocabaş N.A,
Karakaya A.E. Comparison of genotoxicity of
sevoflurane and isoflurane in human lymphocytes
studied in vivo using the comet assay. Mutation
Research 2001;497(1-2):99-107.De Hert SG
5) Van der Linden PJ, ten Broecke PW, Vermeylen KT,
Rodrigus IE, Stockman BA. Effects of desflurane and
sevoflurane on length-dependent regulation of
myocardial function in coronary surgery patients.
Anesthesiology 2001;95(2):357-63.
6) Kharasch ED, Thummel KE. Identification of
cytochrome P450 2E1 as the predominant enzyme
catalyzing human liver microsomal defluorination of
sevoflurane, isoflurane, and methoxyflurane.
Anesthesiology 1993;79(4):795-807.
7) Özatamer O, Alkış N, Batislam Y. Fast-Tracking.
Anestezide Güncel Konular, Ankara, 2002:417.
8) Patel SS, Goa KL. Desflurane. A review of its
pharmacodynamic and pharmacokinetic properties and
its efficacy in general anaesthesia. Drug 1995;50(4):742-
67.
9) Halliwell B. Reactive oxygen species in living
systems: source, biochemistry, and role in human disease.
Am J Med 1991;91(3):14-22.
10) Kayhan Z. Klinik Anestezi, Logos Yayıncılık Tic.
Aş. Ankara, 1997, 270-91.
11) Muggli D. Physiological requrements of vitamen E as
a function of the amount and type of polyunsatured fatty
acid. World Rev Nutr Diet 1994;75:166-8.Murphy PG
12) Bennett JR, Myers DS, Davies MJ, Jones JG. The
effect of propofol anaesthesia on free radical-induced
lipid peroxidation in rat liver microsomes. Eur J
Anaesthesiol 1993;10(4):261-66.Rosenberg PH
13) KallioH. Operating-theatre gas pollution and
chromosomes. Lancet 1977;2(8035):452-3.
14) Ronald D. Miller:Anesthesia. Churchill Livingstone.
Philadelphia, 2000, 167.Hoerauf KH
15) Wiesner G, Schroegendorfer KF, Jobst BP, Spacek A,
Harth M, Sator-Katzenschlager S, Rüdiger HW. Waste
anaesthetic gases induce sister chromatid exchanges in
lymphocytes of operating room personel. British.Journal
of Anaesthasia 1999;82(5):764-66.
16) Karpinski T.M, Kostrzewska-Poczekaj M, Stachecki
I, Mikstacki A, Szyfter K. Genotoxicity of the volatile
anaesthetic desflurane in human lymphocytes in vitro
established by comet assay . J.Appl Genet
2005;46(3):319-24.
17) Szyfter K, Szule R, Mikstacki A, Stachecki I,
Rydzanicz M, Jaloszynski P. Genotoxicity of inhalation
anaesthetics:DNAlesions generated by sevoflurane in vitro
and in vivo. J.Appl.Genet 2004;45(3):369-74.Bilban M
18) Jakopin CB, Ogrinc D. Cytogenetic tests performed on
operating room personel(the use of anaesthetic gases). Int
Arch Occup Environ Health 2005;78(1):60-4.
19) Natarajan D, Santhiya ST. Cytogenetic damage in
operation theatre personel. Anaesthesia 1990;45(7):574-77.
20) Husum B, Nieburh E, Wulf HC, Norgaard I. Sister
chromatid exchanges and structural chromosome
aberrations in lymphocytes in operating room personel.
Acta Anaesthesiology Scand 1983;27(3):262-65.
21) Hoerauf K, Lierz M, Wiesner G, Schroegendorfer K,
Lierz P, Spacek A, Brunnberg L, Nusse M. Genetic damage
in operating room personel exposed to ısoflurane and
nitrous oxide. Occup Environ Med 1999;56(7):433-37.
Sardaş S
22) Aygün N, Gamli M, Unal Y, Unal N, Berk N, Karakaya
AE. Use of alkaline comet assay to detect DNA damages in
lymphocytes of operating room personel occupationally
exposed to anaesthetic gases. Mutat Res 1998;418(2-3):93-
100. Bruce DL
23) Eide KA, Linde HW, Eckenhoff JE. Causes of death
among anesthesiologists: a 20-year survey. Anesthesiology
1968;29(3):565-9.
24) Rozdaj R, Kasuba V, Jazbec A. Preliminary study of
cytogenetic damage in personel exposed to anaesthetic
gases. Mutagenesis 2001;16(2):139-43. Reitz M
25) Antonini-Rumpf E, Lanz E. DNA single-strand
breaks in peripheral human lymphocytes after
anaesthesia with isoflurane-nitrous oxide-oxygen.
Arzneimittelforschung 1993;43(12):1258-61.
Jaloszyński P
26) Kujawski M, Wasowicz M, Szulc R, Szyfter K.
Genotoxicity of inhalation anaesthetics halotane and
isoflurane in human lymphocytes studied in vitro using
the comet assay. Mutat Res 1999;439(2):199-206. Coate
WB
27)Kapp RW Jr, Lewis TR. Chronic exposure to low
concentrations of halotan-nitrous oxide;reproductive
and cytogenetic effect in the rat. Anaesthesiology 1979;
50(4):310-8. Natarajan D
28) Santhiya ST. Cytogenetic damage in operation
theatre personel. Anaesthesia 1990;45(7):574-7.Chang
WP
29)Lee S, Tu J, Hseu S. Increased micronucleus
formation in nurses with occupational nitrous oxide
exposure in operating theaters. Environ Mol Mutagen
1996;27(2):93-7. Bigatti P
30)Lamberti L, Ardito G, Armellino F, Malanetto C.
Chromosome aberrations and sister chromatid exchanges
in occupationally exposed workers. Med Lav
1985;76(4):334-9. Murphy PG
31)Myers DS, Davies MJ, Webster NR, Jones JG. The
a n t i o x i d a n t p o t e n t i a l o f p r o p o f o l ( 2 , 6 -
diisopropylphenol). Br J Anaesth 1992; 68(6):613-18.
32)Murrell GA, Francis MJ, Bromley L. Modulation of
fibroblast proliferation by oxygen free radicals. Biochem
J 1990; 265(3):659-65. Musacchio E
33)Rizzoli V, Bianchi M, Bindoli A, Galzigna L.
Antioxidant action of propofol on liver microsomes,
mitochondria and brain synaptosomes in the rat.
Pharmacol Toxicol 1991; 69(1):75-77.
34)Aebi H. Catalase in vitro. Methods Enzymol
1984;105:121-26. Ansley DM
35)Sun J, Visser WA, Dolman J, Godin DV, Garnett ME,
Qayumi AK. High dose propofol enhances red cell
antioxidant capacity during CPB in humans. Can J
Anaesth 1999;46(7):641-48. Johnson ME
36)Sill JC, Uhl CB, Halsey TJ, Gores GJ. Effect of volatile
anesthetics on hydrogen peroxide-induced injury in aortic
and pulmonary arterial endothelial cells. Anesthesiology
1996;84(1):103-16. Allaouchiche B
37)Debon R, Goudable J, Chassard D, Duflo F. Oxidative
stress status during exposure to propofol, sevoflurane and
desflurane. Anesth Analg 2001;93(4):981-85.Koksal GM
38)Sayilgan C, Aydin S, Uzun H, Oz H. The effects of
sevoflurane and desflurane on lipid peroxidation during
laparoscopic cholecystectomy. Eur J Anaesthesiol
2004;21(3):217-20. Dikmen B
39)Unal Y, Pampal HK, Nurlu N, Kurtipek O, Canbolat O,
Ozoğul C, Kavutcu M. Effects of repeated desflurane and
sevoflurane anaesthesia on enzymatic free radikal
scavanger system. Mol Cell Biochem 2007;294(1-2):31-37.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
